Oncology Research & Development

In Q4 2017, HS Pharmaceuticals will be initiating a new collaborative cancer research effort between The Medical University of South Carolina in Charleston, South Carolina and LifeArc (formerly The Medical Research Council) at Cambridge University in Cambridge, England. HS Pharmaceuticals has licensed technology from LifeArc that is focused on the silica nanoclusters application to T-cell…